Our laboratory in Chongqing, China, established in 2017, provides GxP bioanalytical services. Its core leadership has extensive working experience in the US and China CRO industry.
Lab Description
The site employs 70 scientists operating from 3,500 square meters of purpose-built, state-of-the-art analytical labs.
It is equipped with the world’s most advanced instruments, while its quality assurance system is established in strict accordance with domestic and foreign laws and regulations related to bioanalysis.
The site is the industry leader in China in the bioanalysis of oligonucleotide drugs and mRNA vaccines (PK/PD and ADA), liposomal drug (free and encapsulated drug), ultra-sensitive assays for inhalation drugs, and biomarker assays.
Resolian Bioanalytics Chongqing Building B9, Dadi Enterprise Park, No. 88 Fenghe Road, Beibei District, Chongqing
Unique Site-specific Expertise
Large molecule (LBA & LC-MS) bioanalysis (including oligonucleotides)
Ultra-high sensitivity methods
qPCR (including mRNA vaccines and BSL-2 [China level])
Liposomal drugs (free drug, encapsulated drug and total drug concentrations)
Micellar drugs (free drug and total drug concentrations)
Lipid drug carriers (PEG20000, PEI25000, PEG2000-DMG, Dlin-MC3, ALC-0315 and ALC-0159 etc.)
Vitamin D and K analogdrugs (Calcitriol, Alfacalcidol, Eldecalcitol, Paracalcitol, Vitamin K1, Vitamin K2, etc.)